China Should Develop Its AIDS Vaccine, Expert Says
Posted on: Saturday, 19 November 2005, 09:00 CST
China should develop its AIDS vaccine, expert says
BEIJING, Nov. 18 (Xinhua) -- China should develop its own AIDS vaccine and the work should be put on the agenda as soon as possible, said a Harvard University professor here Friday.
The priority for China's AIDS vaccine research is to develop a vaccine suitable for the physical conditions of Chinese people as soon as possible, said Dr. Yichen Lu with Harvard School of Public Health Friday at Beijing Forum 2005.
China has its own advantages in developing AIDS vaccine despite its lag behind the advanced countries for at least five years, he said.
Different races require different types of vaccines, and lots of experiments have to be conducted, he said.
The research is much more difficult than what is expected. To develop an AIDS vaccine needs cooperation of the whole world, especially developing countries, said Dr. Lu at the Public Health panel session.
Vaccine is the only effective way to fight against AIDS in the long run. Currently the United States is the most advanced in AIDS vaccine research, and the third phase of the test of such a vaccine on human body is expected to begin next year.
The three-day Beijing Forum 2005, sponsored by Peking University, is an international academic forum and attracts over 500 world renowned scholars from China and abroad. Its theme is "The harmony of civilization and prosperity for all."
Source: Xinhua News Agency - CEIS
Related Articles
- Six Products of Telestone Have Been Selected into 'The 3rd Catalog of the Self-Developed Products in Beijing City'
- China Tests Research Equipments for Moon-Probing Project
- Environmental Pollution Major Problem in China's Development: Premier
- GlaxoSmithKline Joins Combined White House, Industry, UN Agencies Effort to Fight Pediatric AIDS in Developing Countries
- China Exclusive: China Develops AIDS Drug With Independent IPR
- China Develops New Oil Field in Bohai Sea
- Wyse Technology Establishes Asia Pacific Headquarters and Research and Development Center in Beijing
- China Develops Reagent for Testing Drug Resistance of Hepatitis B Virus
- China Develops Typing Reagent of Hematopoietic Stem Cell
- Chinese Anti-Cancer Vaccine Approved for Clinical Research
User Comments (0)

RSS Feeds